Indiana’s attorney general has initiated an antitrust lawsuit against several pharmaceutical companies, including Pfizer, Viatria, Mylan, King Pharmaceuticals, and Meridian Medical Technologies. The complaint alleges these firms conspired to inflate the prices of epinephrine injectors, commonly known as “EpiPens,” by 600%. This legal action is part of a larger wave of lawsuits across the United States, challenging pharmaceutical companies on similar grounds of monopolistic practices to increase the cost of vital medications.
For more details on this case, you can access the report on the Law.com article.